LCLaura Cobos-Marín

Laura Cobos-Marín

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura Cobos-Marín has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development of a recombinant MOMP-based indirect ELISA for the serodiagnosis of caprine chlamydiasis

    by Miguel A. De la Rosa-Ramos, Fernando M. Guerra-Infante, Ángela Roque-López, Cinthya I. Santiago-Barrientos, Laura Cobos-Marín, José Luis Gutiérrez-Hernández, Gabriela Palomares-Resendiz, Rigoberto Hernández-Castro, Beatriz Arellano-Reynoso, Francisco Suárez-Güemes

    Caprine chlamydiasis, caused primarily by Chlamydia abortus, is a major cause of infectious abortion in small ruminants worldwide, leading to substantial economic losses and posing a zoonotic risk; thus, timely diagnosis is essential. The C. abortus ompA gene was cloned into the pLATE vector and expressed in Escherichia coli. Recombinant MOMP (rMOMP) was purified by affinity chromatography and evaluated as a diagnostic antigen using 82 caprine serum samples in comparison with a commercial kit. Method robustness, precision, and sample stability (freeze-thaw cycles and thermal stress) were assessed in accordance with international validation guidelines. The CA-iELISA demonstrated solid diagnostic performance, achieving an Area Under the Curve (AUC) of 0.965, a sensitivity of 91.4%, and a specificity of 89.4% relative to the commercial kit. The assay showed high repeatability (11.13% CV) and intermediate precision (17.91% CV), both well within the 20% acceptance threshold. Robustness testing indicated thermal stability but identified incubation time as a critical control parameter. Sample stability studies confirmed that serum remains reliable for up to 7 days under refrigeration (4 °C); however, aliquoting is strongly recommended to prevent the signal loss (~ 40%) observed after a single freeze-thaw cycle. The rMOMP-based CA-iELISA represents a viable candidate diagnostic assay, serving as a robust and sensitive tool for the serological screening of caprine chlamydiasis. This positions it as a potential primary epidemiological screening tool for disease surveillance and control programs in goats, particularly in resource-limited regions lacking specialized diagnostic infrastructure.

  • Open Access

    Microenvironment M1/M2 macrophages and tumoral progression vary within C57BL/6 mice from same substrain in prostate cancer model

    by P. Hernández-Peralta, R. Chacón-Salinas, M. I. Gracia-Mora, G. Soldevila, J. Moreno-Rodríguez, L. Cobos-Marín

    Cancer mice models are critical for immune-oncology research; they provide conditions to explore tumor immunoenviroment aiming to advance knowledge and treatment development. Often, research groups breed their own mice colonies. To assess the effect of C57BL/6 mice breeding nuclei in prostate cancer development and intratumoral macrophage populations, an isotransplantation experiment was performed. C57BL/6J mice from two breeding nuclei (nA and nB) were employed for prostate adenocarcinoma TRAMP-C1 cell implantation; tumor growth period and intratumoral macrophage profile were measured. BL/6nB mice (54%) showed tumor implantation after 69-day growth period while BL/6nA implantation reached 100% across tumor growth period (28 days). No difference in total macrophage populations was observed between groups within several tumoral regions; significantly higher M2 macrophage profile was observed in tumor microenvironments from both mice groups. Nevertheless, BL/6nB tumors showed around twice the population of M1 profile (11–27%) than BL6nA (4–15%) and less non-polarized macrophages. The M1:M2 average ratio was 1:8 for group A and 1:4 for B. Our results demonstrate different tumor progression and intratumoral macrophage populations among mice from the same substrain. Data obtained in this study shows the relevance of animal source renewal for better control of murine cancer model variables.


  • Open Access

    Retrospective seroepidemiological study of small ruminant lentivirus, paratuberculosis and brucellosis in goats from Mexico, based on multiplex assay

    by Ana Delia Rodríguez-Cortez, Cecilia Montoya-Carrillo, Héctor Daniel Nájera-Rivera, Alejandro Zaldivar-Gómez, Enrique Herrera Lopez, Oscar Rico-Chavez, Hugo Ramírez Álvarez, Alejandro De Las Peñas, Efrén Díaz-Aparicio, Laura Cobos-Marin

    Mexican goat production systems face infection risks from Brucella melitensis, small ruminant lentivirus (SRLv) and Mycobacterium avium subsp. paratuberculosis (MAP); agents that cause great economic losses and directly affect public health (brucellosis and paratuberculosis [PTb]). Currently, there are no diagnostic tests applicable at large scale nor epidemiological information regarding the seroprevalence for these infectious diseases. For this study, a multiplex antibody assay (Luminex®) was used to retrospectively study the seroprevalence of brucellosis, SRLv, and PTb in the sera of 983 goats from nine Mexican states. Sera were obtained between 2014 and 2019. Antibodies against all three infectious diseases were detected in almost all tested samples. The estimated seroprevalence values ranged from 37% to 78% for brucellosis, 21% to 65% for SRLv, and 0% to 13% for PTb. The multiplex assay (Luminex®) is a simple, accessible, efficient, and cost-effective seroprevalence monitoring tool for brucellosis, SRLv, and PTb, and can be used as a large-scale approach.

  • Open Access

    Murine prostate cancer model: microenviroment macrophage populations and tumoral development vary within two C57BL/6 mice breeding nuclei from same substrain

    by Pablo Hernandez-Peralta, Rommel Chacón-Salinas, Isabel Gracia-Mora, Gloria Soldevila, José Moreno-Rodríguez, Laura Cobos-Marín

    Cancer mice models are critical for immune-oncology research; they provide conditions to explore tumor immunoenviroment aiming knowledge advance and treatment development. Often, research groups breed their own mice colonies. To assess the effect of C57BL/6 mice breeding nuclei in prostate cancer development and intratumoral macrophage populations, a isotransplantation experiment was performed. C57BL/6J mice from two breeding nuclei (nA and nB) were employed for prostate adenocarcinoma TRAMP-C1 cells implantation, tumor growth period and intratumoral macrophage profile were measured. 54% of BL/6nB mice showed tumor implantation and growth period was 69 days, meanwhile BL/6nA implantation reached 100% and tumor growth occur in 28 days. No difference of total macrophage populations was observed between groups within several tumoral regions, significant higher M2 macrophage profile were founded in tumor microenviroment from both mice groups. Nevertheless, BL/6nB tumors showed around twice populations of M1 profile (11% -27%) than BL6nA (4% -15%) and less non-polarized macrophages. M2:M1 average ratio was 8:1 for A group and 4.2:1 for B. Our results demonstrate different tumor progression and intratumoral macrophage populations among mice from same substrain. Data obtained in this study shows the relevance of animal sources renewing for better control of murine cancer model variables.

  • Open Access

    Multiplex assay for the simultaneous detection of antibodies against small ruminant lentivirus, Mycobacterium avium subsp. paratuberculosis, and Brucella melitensis in goats

    by Héctor D. Nájera-Rivera, Ana D. Rodríguez-Cortez, María G. Anaya-Santillán, Efrén Díaz-Aparicio, Ariadna V. Ramos-Rodríguez, Irlanda J. Siliceo-Cantero, Norma C. Vázquez-Franco, Erik Nieto-Patlán, Alejandro De Las Peñas, Liliana M. Valdés-Vázquez, et al.

    Background and Aim: Brucellosis, paratuberculosis (PTb), and infections caused by small ruminant lentivirus (SRLV), formerly known as caprine arthritis encephalitis virus (CAEV), adversely affect goat production systems. Nonetheless, commonly used diagnostic tests can only determine one analyte at a time, increasing disease surveillance costs, and limiting their routine use. This study aimed to design and validate a multiplex assay for antibody detection against these three diseases simultaneously. Materials and Methods: Two recombinant proteins from the SRLV (p16 and gp38), the native hapten of Brucella melitensis, and the paratuberculosis-protoplasmic antigen 3 from Mycobacterium avium subsp. paratuberculosis (MAP) were used to devise and assess a multiplex assay. Conditions for the Luminex® multiplex test were established and validated by sensitivity, specificity, repeatability, and reproducibility parameters. Cut-off points for each antigen were also established. Results: The 3-plex assay had high sensitivity (84%) and specificity (95%). The maximum coefficients of variation were 23.8% and 20.5% for negative and positive control samples, respectively. The p16 and gp38 SRLV antigens are 97% and 95%, similar to the CAEV sequence found in GenBank, respectively. Conclusion: The multiplex test can be effectively used for the simultaneous detection of antibodies against SRLV, MAP and B. melitensis in goats. Keywords: antibody detection, brucellosis, Luminex®, paratuberculosis, serological test, small ruminant lentivirus.


  • Agave mapisaga aqueous extract shows in vitro and in vivo activity on murine prostate cancer cells

    by Universidad Nacional Autonoma de Mexico, Pablo Hernandez-Peralta, David A Garcia-Espejo, Maria I Gracia-Mora, Marco A Velasco-Velasquez, Laura Cobos-Marin

    Plants are a source of multiple antineoplastic treatments. However, the effect of many species used in traditional medicine has yet to be demonstrated. In this work, the taxonomic identification of Agave mapisagawas made and a high-performance liquid chromatography-mass spectrometry (HPLC-MS) study suggested the presence of the aglycone hecogenin, which is part of compounds such as agavoside C and cantalasaponin 4. The antineoplastic activity of an aqueous extract was tested in vitroand in vivoon PEC-Src epithelial murine prostate cancer cells. In vitrostudy revelead a significant chemosensivity at 0.125mg/100μL(p=0.0001). Also, in in vivo, using an isotransplantation model with 1x106cells subcutaneously, it was observed that the group treated with 50 mg/kg presented a lower tumor implantation compared with the control without treatment (p=0.04).


  • Open Access

    Altered neutrophil-to-lymphocyte ratio in sepsis secondary to canine parvoviral enteritis treated with and without an immunomodulator in puppies

    by Adriana I. Muñoz, José Luis Maldonado-García, Ana Fragozo, Luis Vallejo-Castillo, Amellalli Lucas-Gonzalez, Ismael Trejo-Martínez, Lenin Pavón, Gilberto Pérez-Sánchez, Laura Cobos-Marin, Sonia Mayra Pérez-Tapia

    Neutrophil-to-lymphocyte ratio (NLR) is a cheap and easy-to-obtain biomarker that mirrors the balance between innate and adaptive immunity. Cortisol and catecholamines have been identified as major drivers of NLR. High cortisol levels increase neutrophils while simultaneously decreasing lymphocyte counts. Likewise, endogenous catecholamines may cause leukocytosis and lymphopenia. Thus, NLR allows us to monitor patient severity in conditions such as sepsis. Twenty-six puppies with sepsis secondary to canine parvoviral enteritis were treated with and without an immunomodulator. Our group determined the NLR and the plasmatic cortisol levels by chemiluminescence, and norepinephrine (NE) and epinephrine (E) by HPLC during the first 72 h of clinical follow-up. Our results showed that at admission puppies presented an NLR value of 1.8, cortisol of 314.9 nmol/L, NE 3.7, and E 3.3 pmol/mL. Both treatments decreased admission NLR values after 24 h of treatment. However, only the puppies treated with the immunomodulator (I) remained without significant changes in NLR (0.7–1.4) compared to the CT group, and that showed a significant difference (P < 0.01) in their NLR value (0.4–4.6). In addition, we found significant differences in the slope values between the admission and final values of NLR (P < 0.005), cortisol (P < 0.02), and E (P < 0.05) between treatments. Then, our data suggest that the immunomodulator positively affects the number of lymphocytes and neutrophils involved in NLR as well as major drivers like cortisol and epinephrine, which is reflected in clinical parameters and survival.


  • Towards the development of an epitope-focused vaccine for SARS-CoV-2

    by Jacquelynne Cervantes-Torres, Sergio Rosales-Mendoza, Carlos Cabello, Laura Montero, Juan Hernandez-Aceves, Guillermo Granados, Arturo Calderón-Gallegos, Francisco Zúñiga-Flores, Mirna Ruiz-Rivera, Julio César Abarca-Magaña, et al.


  • Open Access

    Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid

    by Adriana I. Muñoz, Luis Vallejo-Castillo, Ana Fragozo, Said Vázquez-Leyva, Lenin Pavón, Gilberto Pérez-Sánchez, Rodolfo Soria-Castro, Gabriela Mellado-Sánchez, Laura Cobos-Marin, Sonia Mayra Pérez-Tapia

    Canine parvovirus type II (CPV-2) infection induces canine parvoviral enteritis (CPE), which in turn promotes sepsis and systemic inflammatory response syndrome (SIRS). Mortality in this disease is usually registered within 48–72 h post-hospitalization, the critical period of the illness. It has been recently described that the use of an immunomodulator, whose major component is monomeric ubiquitin (mUb) without the last two glycine residues (Ub∆GG), in pediatric human patients with sepsis augments survival. It is known that CXCR4 is the cell receptor of extracellular ubiquitin in humans. This work aimed to explore the effect of one immunomodulator (human Dialyzable Leukocyte Extract-hDLE) as a therapeutic auxiliary in puppies with sepsis and SIRS induced by CPE. We studied two groups of puppies with CPV-2 infection confirmed by polymerase chain reaction. The first group received conventional treatment (CT) and vehicle (V), while the second group received CT plus the immunomodulator (I). We assessed both groups' survival, clinical condition, number of erythrocytes, neutrophils, and lymphocytes during the hospitalization period. In addition, hematocrit, hemoglobin, plasma proteins and cortisol values, as well as norepinephrine/epinephrine and serotonin concentration were determined. Puppies treated with CT + I showed 81% survival, mild clinical signs, and a significant decrease in circulating neutrophils and lymphocytes in the critical period of the treatment. In contrast, the CT + V group presented a survival of 42%, severe clinical status, and no improvement of the parameters evaluated in the critical period of the disease. We determined in silico that human Ub∆GG can bind to dog CXCR4. In conclusion, the administration of a human immunomodulator (0.5 mg/day × 5 days) to puppies with CPE under six months of age reduces the severity of clinical signs, increases survival, and modulates inflammatory cell parameters. Further studies are necessary to take full advantage of these clinical findings, which might be mediated by the human Ub∆GG to canine CXCR4 interaction.


  • Open Access

    Vaccination of nulliparous gilts against porcine epidemic diarrhoea can result in low neutralising antibody titres and high litter mortality

    by Lourdes M. Galindo-Castañeda, Rommel Chacón-Salinas, Víctor Quintero, José I. Sanchez-Betancourt, Laura Cobos-Marín

    Porcine epidemic diarrhoea (PED) is a disease caused by an alphacoronavirus and the symptoms include watery diarrhoea and vomiting, with more than 80% mortality amongst newborn piglets. The placentation in sows hinders the transference of antibodies to the foetus, therefore, the vaccination of pregnant females and transference of antibodies to piglets through colostrum are essential to protect them against virus particles. The aim of the study was to determine whether vaccination of nulliparous gilts could induce a high colostrum antibody titre and lower litter mortality, in comparison with vaccinated multiparous sows previously exposed to the virus. Samples of colostrum were obtained from 11 nulliparous gilts with two previous vaccinations (inactivated vaccine) and from 9 multiparous sows with three or more vaccinations (inactivated vaccine) that had been exposed to the virus. The IgG antibody titre was determined through anti-PED enzyme-linked immunosorbent assays (ELISA) and the neutralisation of antibodies was evaluated through plaque reduction neutralisation tests (PRNT). The colostrum of nulliparous gilts, when compared to the multiparous sows, presented a lower anti-PED IgG antibody titre as well as fewer neutralising antibodies. Furthermore, the piglets of multiparous sows experienced higher survival in comparison with those of nulliparous gilts (P<0.01), and mortality was dependent on the 'farrowing' variable (P<0.01). In conclusion, these results show that vaccinating nulliparous gilts does not increase the survival of their piglets in comparison with multiparous sows and that the IgG titres and neutralising antibodies are significantly lower in the former. These results suggest that a modified vaccine strategy is needed for nulliparous gilts to increase piglet protection.